TAL
FPRX

TIG Advisors LLC’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

TIG Advisors LLC’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-432,030
Closed -$16.3M – 492
2021
Q1 		$16.3M Buy
+432,030
New +$10.8M 0.61% 33

TIG Advisors LLC's FPRX Position: Q2 2021 in Review

TIG Advisors LLC sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 432,030 shares — an estimated $16.3M sold.

TIG Advisors LLC first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $16.3M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • TIG Advisors LLC reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • TIG Advisors LLC sold 432,030 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $16.3M.
  • TIG Advisors LLC first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • TIG Advisors LLC's Five Prime Therapeutics, Inc. position peaked at $16.3M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on TIG Advisors LLC's 13F filing for Q2 2021, filed 16 Aug 2021.